MedTrace Logo

Dexamethasone Before Elective Cesarean Section at Term in Reducing Neonatal Respiratory Distress Syndrome

NCT04816097 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 950

Last updated 2021-03-26

No results posted yet for this study

Summary

Prophylactic antenatal administration of corticosteroid enhance fetal lung maturity and reduce the probability of respiratory morbidity in preterm births.

assessment of administration of four doses intramuscular dexamethasone 48h before elective cesarean section at term in reducing the incidence of neonatal respiratory distress syndrome and NICU admission as a result

Conditions

  • C08.381.840.500.475
  • C08.381.840.500.737

Interventions

DRUG

Dexamethasone phosphate

4 doses of dexamethasone 6mg IM 48h before elective CS.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Hassan Awad, Professor · AinSU

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-10-01
Completion
2022-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04816097 on ClinicalTrials.gov